Company intelligence / Profile preview

RxSight

Aliso Viejo, California, United Statesrxsightconnect.com ↗

Ownership: Public · RXST
Employees: ~498
Development stage: Commercial

Overview

RxSight’s Light Adjustable Lens system has demonstrated superior visual outcomes in clinical studies. In a prospective, controlled multicenter study of 600 patients, 92% of eyes achieved results within 0.50 diopters of target manifest refraction spherical equivalent at six months. Patients were approximately twice as likely to achieve 20/20 vision or better without glasses compared to controls with standard monofocal IOLs. The product offers LASIK-like accuracy for cataract patients and corrects as low as 0.50 D of astigmatism—the lowest level approved for treatment.

Therapeutic areas: Ophthalmology
Modalities: Device
Industry: Implantable Medical Devices

Drug pipeline

2 assets

Light Adjustable Lens

Commercial

Indications: Cataract, Astigmatism

1 more asset in the full pipeline.

Request access →

Financials

Market cap: $267M
Total revenue: $33.7M
Enterprise value: $68.8M

Beyond the preview

Go deeper on RxSight.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on RxSight.

Explore the full profile